top of page
All posts
Alzheimer's
ANVISA
Author: Allan Matsui
Author: Jairo Utimi
Author: Claudia Cilento
Author: Nilva Bortoleto
BPF
Cannabidiol
Cancer
Cannabis
Coronavirus
Covid-19
challenges
Epilepsy
pharmaceutical
IFA
pharmaceutical industry
Inovatie
medicines
opportunities
Parkinson
pharmaceuticals
pharmaceutical industry
Author: Camille Rodrigues da Silva
Incremental innovation
Investments
Marketing
News
Incremental innovation
Good Manufacturing Practices
Search
Jun 27, 2024
Challenges in the development and registration of biosimilars
Aug 4, 2023
Six suggestions for a successful Advisory Board
Jul 9, 2023
What is required to file a drug patent application?
Jun 26, 2023
What are the main differences between the ICH guides and the ANVISA requirements?
Feb 9, 2021
COVID-19: What facilities is ANVISA providing at this time of crisis?
E-BOOKS
CONTEÚDOS EXCLUSIVOS PARA AUXILIAR EM
SEU TRABALHO
Acesse
bottom of page
